This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fletcher, J. A. Articles by Morton, C. C. Search for Related Content PubMed PubMed Citation Articles by Fletcher, J. A. Articles by Morton, C. C.

American Journal of Pathology, Vol 138, 1199-1207, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Lineage-restricted clonality in biphasic solid tumors

JA Fletcher, GS Pinkus, N Weidner and CC Morton
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02215.

Cytogenetic analysis of two pulmonary chondroid hamartomas and nine breast adenofibromas revealed clonal chromosome aberrations in both hamartomas and in four breast tumors. To determine lineage of the cells with chromosome aberrations, a combined immunohistochemical/cytogenetic approach was developed that enabled simultaneous ascertainment of cytogenetic aberrations and immunohistochemical features in individual cells. Immunohistochemical/cytogenetic evaluation of one hamartoma and two adenofibromas demonstrated that neoplastic proliferation, in each case, was confined to the mesenchymal (stromal) component, whereas epithelial cells appeared to be reactive. Cytogenetically abnormal short-term cultures of the remaining hamartoma and another of the breast adenofibromas were composed entirely of mesenchymal elements, indicating mesenchymal clonality in those tumors as well. Our findings support redesignation of pulmonary chondroid hamartomas as 'pulmonary chondromas' and suggest that carcinomas developing within fibroadenomas arise from reactive epithelial proliferation. Combined immunohistochemical/cytogenetic analysis might be useful in the development of novel therapeutic approaches that selectively target neoplastic populations within solid tumors.

This article has been cited by other articles:

				N. Franco, L. Arnould, F. Mege, S.-F. Picard, P. Arveux, and S. Lizard-Nacol Comparative Analysis of Molecular Alterations in Fibroadenomas Associated or Not With Breast Cancer Arch Surg, March 1, 2003; 138(3): 291 - 295. [Abstract] [Full Text] [PDF]

				E Kwiatkowska, I Brozek, E Izycka-Swieszewska, J Limon, and A Mackiewicz Novel BRCA2 mutation in a Polish family with hamartoma and two male breast cancers J. Med. Genet., July 1, 2002; 39(7): e35 - 35. [Full Text] [PDF]

				M. G. Tibiletti, F. Sessa, B. Bernasconi, R. Cerutti, B. Broggi, D. Furlan, F. Acquati, M. Bianchi, A. Russo, C. Capella, et al. A Large 6q Deletion Is a Common Cytogenetic Alteration in Fibroadenomas, Pre-malignant Lesions, and Carcinomas of the Breast Clin. Cancer Res., April 1, 2000; 6(4): 1422 - 1431. [Abstract] [Full Text]